<img height="1" width="1" src="https://www.facebook.com/tr?id=1582471781774081&amp;ev=PageView &amp;noscript=1">

Patient-Derived Xenograft Models of Lung Cancer

Lung cancer is the most common type of cancer worldwide, accounting for 13% of the total number of new diagnoses and is classified according to histological type by the size and appearance of cells: non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). Given the prominence of lung cancer diagnosed in the population, predictive preclinical models are essential for treatment development. Our lung cancer models are known to be the most predictive and provide the most accurate approach to evaluating an agents efficacy prior to entering the clinic. Crown Bioscience offers a large collection of over 300 well characterized models including 70 SCLC models, as well as primary and metastatic models. More

Benefits of Crown Bioscience's Lung Cancer PDX Models

Our lung cancer patient-derived xenograft models offer the most translational preclinical model for efficacy screening in cancer drug development. Derived directly from patient tumors and never adapted to grow in vitro, patient derived xenografts reflect the heterogeneity and diversity of the human patient population. PDX give you an accurate, predictive model of how your treatment will perform, well before entering into expensive clinical trials. Crown Bioscience's HuPrime®  PDX models are well characterized for pathology, growth characteristics, and are also genetically/genomically annotated for gene expression, gene copy number, mutations, and fusions.

MODEL NUMBER CANCER TYPE CANCER SUBTYPE DESCRIPTION # per page
LU0009 Lung Cancer NSCLC, SCC Squamous cell carcinoma of right lung, central type with massive necrosis, moderately differentiated, tumor mass: 10cm x 6cm x 5cm. Regional LN: paratracheal LN (2/6). IHC results: HER-1(-), HER-2(-), p53(+ >75%), p170(-), Ki-67(+ 25~50%), p63(+ >75%), VEGF(+), Top-IIa(+ 25~50%), p16(-). CLICK TO VIEW
LU0038 Lung Cancer NSCLC, SCC Squamous cell carcinoma of left lung, grade I-II, tumor mass: 4.5cm x 4cm x 5cm. No maglignant cells adjacent to bronchial stump. Regional LN: hilum of lung LN (0/4), LN of inferior pulmonary ligament (0/2), carina of trachea LN (0/2), LN of left pulmonary vein (2/6). CLICK TO VIEW
LU0299 Lung Cancer NSCLC, SCC Squamous cell carcinoma of lung, no visible malignant cells adjacent to upperside and downside of surgery cut, no malignant cells in LN of hilum of lung LN (0/2) and eminence LN (0/4). CLICK TO VIEW
LU0330 Lung Cancer NSCLC, SCC Squamous cell carcinoma of lung, moderately differentiated. CLICK TO VIEW
LU0350 Lung Cancer NSCLC, SCC Squamous cell carcinoma of lung, no visible malignant cells adjacent to bronchus stump, no malignant cells in LN of inferior pulmonary. veins LN (0/1), subeminence LN (0/3). CLICK TO VIEW
LU0357 Lung Cancer NSCLC, SCC Squamous cell carcinoma of lung, no visible malignant cells adjacent to bronchial stump. Regional LN: hilum of lung LN (0/2), the second hilum of lung (0/2), superior mediastinal LN (0/1), inferior carina of trachea LN (0/2), anterior tracheal LN (0/1). CLICK TO VIEW
LU0367 Lung Cancer NSCLC, SCC Squamous cell carcinoma of lung, no visible malignant cells adjacent to superior stump, no malignant cells in LN of hilum of lung LN (0/8), eminence LN (0/5), paratracheal LN (0/7), inferior pulmonary veins LN (0/1). CLICK TO VIEW
LU0377 Lung Cancer NSCLC, ADC Adenocarcinoma of lung, poorly differentiated, no visible malignant cells adjacent to bronchial stump. Regional LN: hilum of lung LN (0/3), the second hilum of lung LN (0/2), carina of trachea LN (0/1). CLICK TO VIEW
LU0387 Lung Cancer NSCLC, ADC Adenocarcinoma of lung, malignant cells adjacent to bronchial stump. Regional LN: superior mediastinal LN (2/2), inferior carina of trachea LN (1/1), subclavian LN (1/1), hilum of lung LN (3/3), second hilum of lung LN (0/2). CLICK TO VIEW
LU0395 Lung Cancer NSCLC, SCC Adenoacanthoma of lung, no visible malignant cells adjacent to bronchus stump, malignant cells in superior mediastinum LN (1/3), eminence LN (0/2), inferior pulmonary ligament (0/2), and hilum of lung LN (1/2). CLICK TO VIEW
LU0697 Lung Cancer NSCLC, SCC Squamous cell carcinoma of lung. No malignant cells adjacent to bronchus stump. Regional LN: superior mediastinal LN (0/6), inferior carina of trachea LN (0/1). CLICK TO VIEW
LU0741 Lung Cancer NSCLC, SCC Squamous cell carcinoma of lung. No malignant cells adjacent to bronchial stump. Regional LN: LN between lobules of lung (0/2), inferior pulmonary vein LN (0/1), superior mediastinal LN (0/6), subclavian LN (0/2), carina of trachea LN (0/4), right hilum of lung LN (2/2). Tumor embolus were observed in inferior pulmonary vein. CLICK TO VIEW
LU0743 Lung Cancer NSCLC, SCC Squamous cell carcinoma of lung. No malignant cells adjacent to bronchial stump. Regional LN: inferior pulmonary vein LN (0/1), paraaotic LN (0/6), hilum of lung LN (1/6), inferior carina of trachea LN (1/3). Malignant cells invaded pericardium and fiber of chest wall. CLICK TO VIEW
LU0748 Lung Cancer NSCLC, SCC Squamous cell carcinoma of lung. CLICK TO VIEW
LU0755 Lung Cancer NSCLC, SCC NA for clinical diagnosis info. CLICK TO VIEW
LU0858 Lung Cancer NSCLC, SCC Squamous cell carcinoma of lung, poorly differentiated. No malignant cells adjacent to bronchus stump. Regional LN: hilum of lung LN (0/2), superior mediastinal LN (0/2), the tenth group LN (0/5). CLICK TO VIEW
LU0860 Lung Cancer Neurofibroma NA for clinical diagnosis info. CLICK TO VIEW
LU0861 Lung Cancer NSCLC, SCC Squamous cell carcinoma of lung. No maglignant cells adjacent to bronchial stump. Regional LN: hilum of lung LN (0/1). CLICK TO VIEW
LU0876 Lung Cancer NSCLC, SCC NA for clinical diagnosis info. CLICK TO VIEW
LU0884 Lung Cancer NSCLC, SCC Squamous cell carcinoma in lung. Malignant cells adjacent to bronchus stump. Regional LN: hilum of lung LN (0/1), the second hilum of lung LN (0/2), superior mediastinal LN (0/2), carina of trachea LN (0/2), LN between lobules of lung (0/1). CLICK TO VIEW
LU0894 Lung Cancer NSCLC, SCC Squamous cell carcinoma of lung. No malignant cells adjacent to bronchus stump. Regional LN: hilum of lung LN (0/1), anterior esophageal and posterior vena cava LN (0/2), carina of trachea LN (0/2). CLICK TO VIEW
LU1116 Lung Cancer NSCLC, SCC Squamous cell carcinoma of left lung. CLICK TO VIEW
LU1143 Lung Cancer NSCLC, SCC Squamous cell carcinoma of right lung. CLICK TO VIEW
LU1144 Lung Cancer NSCLC Adenocarcinoma of right lung, poorly differentiated. CLICK TO VIEW
LU1147 Lung Cancer NSCLC, ADC Poorly differentiated cancer of inferior left lung, tumor mass: 5.5cm x 4.5cm x 4cm, tumor cell appear as infiltrative growth and irregular adenoid type with massive necrosis. CLICK TO VIEW
LU11548 Lung Cancer NSCLC Lung Cancer. Pathol comment: C/W REFERRING DIAGNOSIS. MALIGNANT TUMOR CELLS PRESENT IN CELL BLOCK, CLOT AND CYTOSPIN PREP. CLICK TO VIEW
LU1155 Lung Cancer SCC Poorly differentiated squamous cell carcinoma CLICK TO VIEW
LU11553 Lung Cancer NSCLC Non-Small Cell Lung Cancer, LUNG CARCINOMA. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 80% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
LU11554 Lung Cancer NSCLC NA for clinical diagnosis info. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 60% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
LU11561 Lung Cancer NSCLC NA CLICK TO VIEW
LU11568 Lung Cancer NSCLC Non-Small Cell Lung Cancer. Pathol comment: C/W REFERRING DIAGNOSIS. MALIGNANT TUMOR CELLS PRESENT IN CELL BLOCK SECTION AND CYTOSPIN PREP. CLICK TO VIEW
LU11574 Lung Cancer NSCLC Non-Small Cell Lung Cancer. Pathol comment: C/W REFERRING DIAGNOSIS. MALIGNANT TUMOR CELLS PRESENT IN CELL BLOCK SECTION AND CYTOSPIN PREP. CLICK TO VIEW
LU11575 Lung Cancer NSCLC Non-Small Cell Lung Cancer. METASTATIC CARCINOMA, PD. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 70% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
LU11576 Lung Cancer NSCLC Lung Cancer. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 70% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
LU11584 Lung Cancer NSCLC Non-Small Cell Lung Cancer. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 60% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
LU11586 Lung Cancer NSCLC Non-Small Cell Lung Cancer. CARCINOMA, PD FAVOR NON-SMALL CELL CARCINOMA OF LUNG. Pathol comment: MALIGNANT TUMOR CELLS PRESENT IN CELL BLOCK SECTION AND CYTOSPIN PREP. CLICK TO VIEW
LU11592 Lung Cancer NSCLC Lung Cancer. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 80% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
LU11595 Lung Cancer NSCLC Non-Small Cell Lung Cancer. SQUAMOUS CELL CARCINOMA. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
LU1160 Lung Cancer NSCLC, SCC Poorly differentiated cancer of right lung. CLICK TO VIEW
LU11605 Lung Cancer NSCLC Non-Small Cell Lung Cancer. Pathol comment: C/W REFERRING DIAGNOSIS. MALIGNANT TUMOR CELLS PRESENT IN CELL BLOCK AND CYTOSPIN PREP. CLICK TO VIEW
LU11607 Lung Cancer NSCLC Non-Small Cell Lung Cancer. Pathol comment: C/W REFERRING DIAGNOSIS. NO DEFINITE MALIGNANT TUMOR CELLS PRESENT IN CELL BLOCK SECTION OR CYTOSPIN PREP. CLICK TO VIEW
LU11612 Lung Cancer NSCLC NA for clinical diagnosis info. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 60% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
LU11622 Lung Cancer NSCLC Non-Small Cell Lung Cancer. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 60% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
LU11624 Lung Cancer NSCLC Non-Small Cell Lung Cancer. INVASIVE PD ADENOSQUAMOUS CARCINOMA. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 60% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
LU11631 Lung Cancer NSCLC, ADC N/A CLICK TO VIEW
LU11634 Lung Cancer NSCLC Non-Small Cell Lung Cancer. METASTATIC ADENOCARCINOMA. Pathol comment: C/W REFERRING DIAGNOSIS. MALIGNANT TUMOR CELLS PRESENT IN CELL BLOCK AND CYTOSPIN PREP. CLICK TO VIEW
LU11644 Lung Cancer SCLC Non-Small Cell Lung Cancer. CARCINOMA, PD. Pathol comment: C/W REFERRING DIAGNOSIS. ENTIRE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
LU11652 Lung Cancer NSCLC Non-Small Cell Lung Cancer. Pathol comment: C/W REFERRING DIAGNOSIS. MICROSCOPIC FOCUS OF MALIGNANT TUMOR PRESENT IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
LU11672 Lung Cancer NSCLC Non-Small Cell Lung Cancer. ADENOCARCINOMA. Pathol comment: C/W REFERRING DIAGNOSIS. MALIGNANT TUMOR CELLS PRESENT IN CELL BLOCK AND CYTOSPIN PREP. CLICK TO VIEW
LU11682 Lung Cancer NSCLC Non-Small Cell Lung Cancer. Pathol comment: C/W DIAGNOSIS. APPROX. 70% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. 5% NECROTIC. MALIGNANT CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
LU11684 Lung Cancer NSCLC Non-Small Cell Lung Cancer. Pathol comment: C/W REFERRING DIAGNOSIS. MALIGNANT TUMOR CELLS PRESENT IN CELL BLOCK AND CYTOSPIN PREP. CLICK TO VIEW
LU11685 Lung Cancer NSCLC Non-Small Cell Lung Cancer. Pathol comment: C/W REFERRING DIAGNOSIS. MALIGNANT TUMOR CELLS PRESENT IN CELL BLOCK AND CYTOSPIN PREP. CLICK TO VIEW
LU11692 Lung Cancer NSCLC NA for clinical diagnosis info.. Pathol comment: C/W DIAGNOSIS. APPROX. 70% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. 30% NECROTIC. MALIGNANT CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
LU11693 Lung Cancer NSCLC Non-Small Cell Lung Cancer. Pathol comment: C/W DIAGNOSIS. MALIGNANT TUMOR CELLS PRESENT IN CELL BLOCK AND CYTOSPIN PREP. CLICK TO VIEW
LU11694 Lung Cancer NSCLC Non-Small Cell Lung Cancer. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 60% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
LU11713 Lung Cancer SCLC Non-Small Cell Lung Cancer. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 80% OF THE TISSUE INVOLVED MALIGNANT TUMOR IN SECTIONS EXAMINED. 20% NECROTIC. MALIGNANT CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
LU11714 Lung Cancer SCLC Non-Small Cell Lung Cancer. Non-small cell carcinoma, PD. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 80% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
LU11717 Lung Cancer NSCLC Non-Small Cell Lung Cancer. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 80% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
LU11722 Lung Cancer NSCLC NA for clinical diagnosis info. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 80% OF THE TISSUE INVOLVED MALIGNANT TUMOR IN SECTIONS EXAMINED. 5% NECROTIC. MALIGNANT CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
LU11733 Lung Cancer NSCLC Non-Small Cell Lung Cancer. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 60% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
LU11736 Lung Cancer NSCLC Non-Small Cell Lung Cancer. C/W DIAGNOSIS. MALIGNANT TUMOR CELLS PRESENT IN CELL BLOCK AND CYTOSPIN PREP. CLICK TO VIEW
LU11753 Lung Cancer SCLC Non-Small Cell Lung Cancer. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 80% OF THE TISSUE INVOLVED MALIGNANT TUMOR IN SECTIONS EXAMINED. 10% NECROTIC. MALIGNANT CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
LU11760 Lung Cancer NSCLC N/A CLICK TO VIEW
LU11772 Lung Cancer NSCLC Non-Small Cell Lung Cancer. Non-small cell carcinoma, MD with squamous features. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED MALIGNANT TUMOR IN SECTIONS EXAMINED. 40% NECROTIC. MALIGNANT CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
LU11784 Lung Cancer NSCLC Non-Small Cell Lung Cancer. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
LU11786 Lung Cancer NSCLC Non-Small Cell Lung Cancer. Pathol comment: C/W REFERRING DIAGNOSIS. MALIGNANT TUMOR CELLS PRESENT IN CELL BLOCK AND CYTOSPIN PREP. CLICK TO VIEW
LU11796 Lung Cancer NSCLC Non-Small Cell Lung Cancer. Non-small cell carcinoma, PD. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. 10% NECROTIC. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
LU11801 Lung Cancer NSCLC Non-small cell lung cancer. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. 10% NECROTIC. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
LU11805 Lung Cancer NSCLC Non-small cell lung cancer. Pathol comment: MALIGNANT TUMOR CELLS PRESENT IN CELL BLOCK AND CYTOSPIN PREP. C/W REFERRING DIAGNOSIS. CLICK TO VIEW
LU11815 Lung Cancer NSCLC Non-small cell lung cancer. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 70% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. 20% NECROSIS. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
LU11835 Lung Cancer NSCLC Non-small cell lung cancer, Malignant neoplasm of left upper lobe. Pathol comment: C/W HISTOLOGIC DIAGNOSIS. APPROXIMATELY 100% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. APPROXIMATELY 90% MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREPARATION. CLICK TO VIEW
LU11836 Lung Cancer NSCLC Non-small cell lung cancer with serous features. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 80% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. APPROXIMATELY 80% MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREPARATION. CLICK TO VIEW
LU11842 Lung Cancer NSCLC Non-small cell lung cancer. Metastatic adenocarcinoma of the lung. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 80% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. FOCAL TUMOR NECROSIS. APPROXIMATELY 50% MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREPARATION. CLICK TO VIEW
LU11855 Lung Cancer NSCLC N/A CLICK TO VIEW
LU11856 Lung Cancer NSCLC Non-small cell lung carcinoma, Large cell carcinoma. Pathol comment: APPROXIMATELY 70% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. 20% NECROSIS. C/W NON-SMALL CELL CARCINOMA. APPROXIMATELY 30% MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREPARATION. CLICK TO VIEW
LU11873 Lung Cancer NSCLC Non-small cell lung cancer. Pathol comment: MALIGNANT TUMOR CELLS PRESENT IN CELL BLOCK. APPROXIMATELY 90% MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREPARATION. C/W DIAGNOSIS. CLICK TO VIEW
LU11876 Lung Cancer NSCLC Non-small cell lung cancer. Pathol comment: APPROXIMATELY 60% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. FOCAL TUMOR NECROSIS. C/W NON-SMALL CELL CARCINOMA. APPROXIMATELY 50% MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREPARATION. CLICK TO VIEW
LU11882 Lung Cancer NA NA for clinical diagnosis info. Pathol comment: APPROXIMATELY 70% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. C/W NON-SMALL CELL CARCINOMA. APPROXIMATELY 80% MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREPARATION. CLICK TO VIEW
LU11885 Lung Cancer NSCLC Pathol comment: Non-small cell lung carcinoma. Metastatic carcinoma consistent with lung primary. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 80% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. 50% NECROSIS. APPROXIMATELY 70% MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREPARATION. CLICK TO VIEW
LU11894 Lung Cancer NSCLC Non-small cell lung cancer. Adenocarcinoma. Pathol comment: Approximately 90% of the tissue involved by malignant tumor in sections examined. 10% necrosis. c/w NSCLC. Approximately 30% malignant tumor cells present in cytospin preparation. CLICK TO VIEW
LU11942 Lung Cancer NSCLC Lung carcinoma. CLICK TO VIEW
LU11949 Lung Cancer NSCLC Non-small cell lung cancer, sclerosing bronchioloalveolar carcinoma. CLICK TO VIEW
LU11951 Lung Cancer NSCLC NA for clinical diagnosis info. CLICK TO VIEW
LU11953 Lung Cancer SCLC Non-small cell lung cancer. Submitted specimen consists of malignant epithelial and mesenchymal components. this case was reviewed in intra-department consultation with consensus in interpretation. CLICK TO VIEW
LU11954 Lung Cancer NSCLC Mediastinal mass. Spindle cell sarcoma. CLICK TO VIEW
LU1201 Lung Cancer NA NA CLICK TO VIEW
LU1204 Lung Cancer NSCLC, SCC Poorly differentiated carcinoma of left lung, considered poorly differentiated adenosquamous carcinoma. CLICK TO VIEW
LU1206 Lung Cancer NSCLC, SCC Adenosquamous carcinoma of left lung, tumor mass: 3cm x 3cm x 2.5cm. Regional LN: hilum of lung LN (2/4), the fifth group LN (1/1), the seventh group LN (0/5), the ninth group LN (0/2), paratracheal LN (0/7). CLICK TO VIEW
LU1215 Lung Cancer NSCLC, ADC Adenocarcinoma of right lung, moderately differentiated, tumor mass: 16cm x 14cm x 3cm. No maglignant cells adjacent to bronchial stump. Regional LN: the third group LN (1/2), LN of vena cava (1/1), the second group LN (0/4), the second and forth group LN (0/4), the seventh group LN (0/1), the ninth group LN (0/3), the tenth group LN (0/2), the eleventh group LN (0/1). CLICK TO VIEW
LU1219 Lung Cancer NSCLC, SCC Squamous cell carcinoma CLICK TO VIEW
LU1235 Lung Cancer NSCLC, ADC Adenosquamous carcinoma with part of bronchioloalveolar carcinoma of left lung, tumor mass: 2.5cm x 2cm x 2cm. CLICK TO VIEW
LU1256 Lung Cancer NSCLC, SCC Squamous cell carcinoma of left lung, moderately differentiated. CLICK TO VIEW
LU1258 Lung Cancer NSCLC, SCC Squamous cell carcinoma of lung, moderately differentiated. The tumor forms irregular nest or funicular structures and has an infiltrative growth pattern. Necrosis may be seen. Regional LN: the first group LN (1/1), the ninth group LN (0/1). CLICK TO VIEW
LU1267 Lung Cancer SCLC, NEC Small cell lung cancer. Regional LN: parabronchial LN (1/2), the eleventh group LN (4/4), the seventh group LN (0/1), the tenth group LN (0/2). CLICK TO VIEW
LU1271 Lung Cancer NSCLC, LCLC Large cell undifferentiated carcinoma CLICK TO VIEW
LU1292 Lung Cancer NSCLC, SCC Squmaous cell carcinoma of left lung, poorly differentiated, malignant cells invaded visceral pleura, tumor mass: 3.5cm x 2.8cm x 2.8cm. Regional LN: parabronchial LN (0/2). IHC results: CK5/6(+), CK7(-), P16(-), P53(-), Caspase-3(-). CLICK TO VIEW
LU1302 Lung Cancer NSCLC, SCC Squamous cell carcinoma of left lung, moderately differentiated. CLICK TO VIEW
LU1380 Lung Cancer NSCLC, ADC Adenocarcinoma of right lung with part of bronchioloalveolar carcinoma, grade II+, no malignant cells adjacent to bronchial stump. Regional LN: parabronchial LN (0/5). IHC results: CK7(+), CK5/6(-), TTF1(+), P63(+), Sur(+). CLICK TO VIEW
LU13944 Lung Cancer NSCLC metastaic adenocarcinoma , c/w primary lung origin. Pathol comment: APPROXIMATELY 80% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
LU13952 Lung Cancer LY NA for clinical diagnosis info.. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 60% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
LU13953 Lung Cancer NA NSCLC, metastatic ADC. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 70% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
LU13956 Lung Cancer NSCLC metastaic carcinoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 20% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. APPROXIMATELY 80% MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREPARATION. CLICK TO VIEW
LU14020 Lung Cancer SCLC Small Cell Lung Carcinoma. Pathol comment: C/W DIAGNOSIS. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
LU1419 Lung Cancer NSCLC, SCC N/A CLICK TO VIEW
LU1423 Lung Cancer NSCLC, SCC Squmaous cell carcinoma of left lung, poorly differentiated, no malignant cells invaded visceral pleura, tumor mass: 3.3cm x 3.5cm x 2cm. Regional LN: parabronchial LN (0/6). IHC results: CK5/6(+), CK7(-), Caspase-3(-), BCL-2(+/-), NF-K B(-). CLICK TO VIEW
LU1429 Lung Cancer NSCLC, SCC Squamous cell carcinoma of right lung, grade II-III CLICK TO VIEW
LU1452 Lung Cancer NSCLC, ADC adenocarcinoma of left lung, invaded adipose tissue of mediastinum and pericardium. CLICK TO VIEW
LU1480 Lung Cancer SCLC, NEC Small cell lung cancer, tumor mass: 5 x 3 x 3cm. Regional LN: bronchial stump LN (2/4). CLICK TO VIEW
LU1487 Lung Cancer LY Considered poorly differentiated adenocarcinoma of lung on basis of HE&IHC. CLICK TO VIEW
LU1508 Lung Cancer SCLC, NEC Atypical carcinoid, tumor mass: 3.8cm x 3cm x 2cm. No malignant cells adjacent to adventitia. Regional LN: paratracheal LN (0/5), inferior carina of trachea LN (0/9), hilum of lung LN (0/2), posterior pretracheal vein LN (10/10). IHC results: SYN(+++), CgA(-), NSE(++), CK(+-), CD56(focal +). CLICK TO VIEW
LU1513 Lung Cancer NSCLC, SCC Squamous cell carcinoma, central type, poorly differentiated with necrosis, tumor mass: 3cm x 3cm x 2cm. No malignant cells adjacent to bronchial stump. Regional LN: parabronchial LN (0/5), hilum of lung LN (0/3), inferior aortic arch LN (0/3). CLICK TO VIEW
LU1542 Lung Cancer NSCLC, SCC Squamous cell carcinoma. No malignant cells adjacent to bronchial stump. Regional LN: LN between lobules of lung (0/2), the second hilum of lung LN (0/2), inferior carina of trachea LN (0/3), superior mediastinal LN (0/6). CLICK TO VIEW
LU16057 Lung Cancer NSCLC Non-Small Cell Lung Cancer. Metastatic carcinoma, MPD. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED MALIGNANT TUMOR IN SECTIONS EXAMINED. 10% NECROTIC. MALIGNANT CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
LU1627 Lung Cancer NSCLC, SCC Squamous cell carcinoma of lung. No malignant cells adjacent to bronchial stump. Regional LN: LN of inferior pulmonary veins (0/1), LN between lobules of lung (0/2), hilum of lung LN (1/2), the second hilum of lung LN (1/2), superior-anterior mediastinal LN (0/7), inferior carina of trachea LN (0/4), left pulmonary artery window LN (0/5). CLICK TO VIEW
LU1656 Lung Cancer NSCLC, SCC Carcinosarcoma. No malignant cells adjacent to bronchus stump. Regional LN: the second group LN (0/1), the forth group LN (0/3), inferior carina of trachea LN (0/2), the ninth group LN (0/2), the tenth group LN (0/1), the eleventh group LN (0/2). IHC results: CK(+), Vim(+), Act(-), NSE(-), Syn(-), CD56 (+/-), Chr-A (-). CLICK TO VIEW
LU1661 Lung Cancer NSCLC, SCC Squamous cell carcinoma of lung. No malignant cells adjacent to bronchus stump. Regional LN: hilum of lung LN (0/3), aorticopulmonary window LN (0/1), superior mediastinal LN (0/2), carina of trachea LN (1/4). CLICK TO VIEW
LU1690 Lung Cancer NSCLC, SCC Squamous cell carcinoma of lung, tumor mass: 3cm x 1cm x 2cm. Malignant cells adjacent to bronchus stump. Regional LN: the second hilum of lung LN (3/3), LN of inferior pulmonary ligament (0/3), inferior carina of trachea LN (5/8), LN between lobules of lung (0/1), hilum of lung LN (3/3). CLICK TO VIEW
LU1775 Lung Cancer NSCLC, SCC Squamous cell carcinoma. No malignant cells adjacent to bronchus stump. Regional LN: inferior carina of trachea LN (2/3), superior mediastinal LN (2/4). CLICK TO VIEW
LU1776 Lung Cancer NSCLC, SCC Squamous cell carcinoma. No malignant cells adjacent to bronchus stump. Regional LN: LN between lobules of lung (0/2), superior-anterior mediastinal LN (0/1), carina of trachea LN (0/6), subclavian LN (0/1), superior mediastinal LN (0/2). CLICK TO VIEW
LU1828 Lung Cancer NSCLC, SCC Squamous cell carcinoma. No malignant cells adjacet to bronchus stump. Regional LN: hilum of lung LN (0/4), LN of inferior pulmonary ligament (0/2), carina of trachea LN (0/4). CLICK TO VIEW
LU1868 Lung Cancer NSCLC, SCC Poorly-moderately differentiated squamous cell carcinoma CLICK TO VIEW
LU1901 Lung Cancer NSCLC, LCLC Large cell anaplastic carcinoma CLICK TO VIEW
LU1902 Lung Cancer NSCLC, LCLC Large cell anaplastic carcinoma CLICK TO VIEW
LU2033 Lung Cancer NSCLC, ADC Adenocarcinoma with mixed subtypes CLICK TO VIEW
LU2038 Lung Cancer NSCLC, ADC Adenosquamous carcinoma CLICK TO VIEW
LU2042 Lung Cancer NSCLC, SCC Squamous cell carcinoma, NOS CLICK TO VIEW
LU2049 Lung Cancer NSCLC, ADC Adenocarcinoma, NOS CLICK TO VIEW
LU2051 Lung Cancer NSCLC Large Cell Neuroendocrine Carcinoma Lung CLICK TO VIEW
LU2055 Lung Cancer NSCLC, SCC Squamous cell carcinoma CLICK TO VIEW
LU2057 Lung Cancer SCLC Squamous cell carcinoma, large cell, nonkeratinizing, NOS. Pathology QC on PDX: Small cell carcinoma. CLICK TO VIEW
LU2071 Lung Cancer NSCLC, SCC squamous cell carcinoma CLICK TO VIEW
LU2080 Lung Cancer NSCLC, SCC NA for clinical diagnosis info. Pathology QC: squamous cell carcinoma (P7) CLICK TO VIEW
LU2086 Lung Cancer NSCLC, SCC Lung squaous cell carcinoma. CLICK TO VIEW
LU2403 Lung Cancer NSCLC, ADC N/A CLICK TO VIEW
LU2417 Lung Cancer NA NA for clinical diagnosis info. CLICK TO VIEW
LU2445 Lung Cancer NSCLC Carcinosarcoma. No malignant cells adjacent to bronchus stump. Regional LN: the second group LN (0/1), the forth group LN (0/3), inferior carina of trachea LN (0/2), the ninth group LN (0/2), the tenth group LN (0/1), the eleventh group LN (0/2). IHC results: CK(+), Vim(+), Act(-), NSE(-), Syn(-), CD56 (+/-), Chr-A (-). CLICK TO VIEW
LU2455 Lung Cancer NA NA for clinical diagnosis info. CLICK TO VIEW
LU2503 Lung Cancer NSCLC, ADC Moderately-poorly differentiated adenosquamous carcinoma CLICK TO VIEW
LU2504 Lung Cancer NSCLC, SCC Squamous cell carcinoma, moderately-well differentiated. No malignant cells adjacent to bronchus stump. Regional LN: hilum of lung LN (0/3), IHC: P63(++),TTF-1(-), CK5(+++),CK14(+++), EGFR(+),Ki-67(10%+),CK7(+/-),ERCC-1(-),RRM-1(-),Tubulin b3(-),ER(-),ER-b(-).1. (Group 10) 2. (group 7) no metastasis in LN (0/1,0/1). CLICK TO VIEW
LU2505 Lung Cancer NSCLC, ADC Adenocarcinoma, poorly differentiated, malignant cells diffuse infiltrated in lung with massive necrosis. No malignant cells adjacet to stump. Regional LN: hilum of lung LN (3/3), the eleventh group LN (0/2),the fivth group LN (0/1), the seventh group LN (0/3). IHC results: Syn(-), CHgA(+/-), TTF-1(+++), SPB(-), CK7(++), EGFR(-), ER(-), ER-(++), CK20(-), RRM-1(++), CEA(+++), CK34BE12(+), Tubulin b3(+), ERCC-1(++), Ki-67(50%+), CD34(blood vessel +). CLICK TO VIEW
LU2509 Lung Cancer PNET Primitive neuroectodermal tumor (PNET) of left lung.IHC results: Vimentin(+++), CD99(++), Ki67(+)<40%, Bcl-2(++), CD56(++), S-100(+/-). CLICK TO VIEW
LU2511 Lung Cancer NSCLC, LCLC Large cell undifferentiated carcinoma, tumor mass: 7cm x 6cm x 6cm, no visible malignant cells adjacent to bronchial stump. Regional LN: carina of trachea LN (0/2), the sixth group LN (0/2), inferior pulmonary vein LN (0/2), carina of trachea LN (0/2), superior mediastinal LN (0/1),LN between lobules of lung (0/1), the fourth group LN (0/3). IHC results: CK(+), Vim(-), EMA(+), P63(-/+), CK7(-), Syn(+), CD56(-). CLICK TO VIEW
LU2512 Lung Cancer NSCLC, ADC Adenocarcinoma of lung, tumor mass: 4cm x 4cm x 3cm, malignant cells invaded soft tissues external bronchial stump. Regional LN: the fourth group LN (4/4), the ninth group LN (1/2), inferior carina of trachea LN (1/2), the second group LN (3/3), the second carina of trachea LN (2/2). CLICK TO VIEW
LU2514 Lung Cancer SCLC, NEC Small cell carcinoma, tumor mass: 7cm x 4.5cm x 3cm, no visible malignant cells adjacent to bronchial stump. Regional LN: hilum of lung LN (0/1), LN of inferior pulmonary ligament (0/1). IHC results: CK(-/+), NSE(+), Syn(+), CD56(+), Chr-A(+/-). CLICK TO VIEW
LU2527 Lung Cancer NEC Neuroendocrine carcinoma of lung, moderately differentiated, tumor mass: 4.5 x 3.2 x 3cm. Regional LN: hilum of lung LN (2/2), NO.5 LN 0/4, NO.9 LN 0/1. IHC results: CK7(-), CK34(-), CK5/6(-), CEA(-), P63(-), Ki67(++)90%, CgA(+), Syn(-), SCLC(++), TTF(++), ERCC-1(-), VEGFR(++), TP(-), Her-2(-), EGFR(++), B-microtubulin(+++). CLICK TO VIEW
LU2529 Lung Cancer Clear cell carcinoma, sarcomatoid carcinoma Clear cell carcinoma with neuroendocrine carcinoma, tumor mass: 2.5 x 2 x 2.5cm. Regional LN: LN between lobules of lung (0/1), inferior carina of trachea LN (0/2), LN of inferior parapulmonary vein (0/2), superior mediastinal LN (1/2), hilum of lung LN (0/2). IHC results: CK(+), Vim(+/-), HMB45(-), S-100(-/+), Mart-1(-), NSE(+), Syn(-), CD56(-), Chr-A(+). CLICK TO VIEW
LU2535 Lung Cancer NSCLC, ADC Poorly differentiated adenocarcinoma of lung, tumor mass: 4.5 x 4 x 2.5cm. Regional LN: hilum of lung LN (0/1), superior mediastinal LN (3/9), LN of inferior parapulmonary vein (1/1), inferior carina of trachea LN (0/9). IHC results: CK8/18(+),CK7(+++), CK34(+), CK5/6(-), K167(+)10%, CgA(-), HMB45(-), ERCC-1(-), VECFR(++), TP(-), Her-2(+), Syn(-), TTF(++), BGFR(++), B-microtubulin(+++), P53(++), CD34(blood vessel +). CLICK TO VIEW
LU2537 Lung Cancer NSCLC Lung cancer (adenoacanthoma) metastasis to lymphonodi. Regional LN: right neck triangle LN (5/5), right superior clavicular LN (5/5). CLICK TO VIEW
LU2540 Lung Cancer NSCLC, SCC Squamous cell carcinoma of lung CLICK TO VIEW
LU2551 Lung Cancer NA NA for clinical diagnosis info. CLICK TO VIEW
LU2555 Lung Cancer NSCLC, ADC NA for clinical diagnosis info. CLICK TO VIEW
LU2567 Lung Cancer NEC NA CLICK TO VIEW
LU2569 Lung Cancer NA NA for clinical diagnosis info. CLICK TO VIEW
LU2675 Lung Cancer NA NA for clinical diagnosis info. CLICK TO VIEW
LU2804 Lung Cancer NA NA CLICK TO VIEW
LU3007 Lung Cancer NSCLC, SCC Squamous cell carcinoma of left lung, grade II-III, no visible malignant cells adjacent to visceral pleura. IHC results: CK5/6(+), CK7(-), TTF(-), SPA(-), VEGF(-). Regional LN: parabronchial LN (0/5), the forth group LN (0/1), the tenth group LN (0/3), the eleventh group LN (0/1). CLICK TO VIEW
LU3057 Lung Cancer NSCLC, ADC Poorly differentiated adenocarcinoma of lung, tumor mass: 1.5 x 2 x 1.5cm. Massive malignant cells and lymphocyte infiltrating may be seen in hyperplastic fibrous tissue. IHC results: CK7(+), CK5/6(-), P53(+), VEGF(+/-). CLICK TO VIEW
LU3073 Lung Cancer NSCLC, SCC Squamous cell carcinoma of lung, grade II-III CLICK TO VIEW
LU3075 Lung Cancer NSCLC, SCC NSCLC, tumor mass: 2.5 x 1.5 x 1cm. CLICK TO VIEW
LU3133 Lung Cancer NSCLC, ADS Adenosquamous carcinoma of lung with necrosis. Regional LN: parabronchial LN (0/4), paratracheal LN (0/1), inferior carina of trachea LN (0/1), hilum of lung LN (0/2), LN between lobules of lung (0/3). CLICK TO VIEW
LU3345 Lung Cancer SCC Lung: poorly differentiated squamous cell carcinoma. Two of twelve lymph nodes involved by metastatic carcinoma (2/12) CLICK TO VIEW
LU5137 Lung Cancer NSCLC, LCNEC large cell carcinoma large cell neuroendocrine carcinoma CLICK TO VIEW
LU5138 Lung Cancer NSCLC, SCC squamous carcinomasquamous cell carcinoma CLICK TO VIEW
LU5139 Lung Cancer SCLC squamous carcinomamoderately-differentiated invasive squamous cell carcinoma CLICK TO VIEW
LU5146 Lung Cancer NSCLC, SCC squamous carcinomapoorly-differentiated squamous cell carcinoma CLICK TO VIEW
LU5147 Lung Cancer NSCLC, SCC squamous carcinomasquamous cell carcinoma CLICK TO VIEW
LU5148 Lung Cancer NSCLC, SCC squamous carcinomasquamous cell carcinoma CLICK TO VIEW
LU5149 Lung Cancer NSCLC, SCC squamous carcinomametastatic poorly differentiated carcinoma CLICK TO VIEW
LU5150 Lung Cancer NSCLC, ADC adenocarcinoma metastatic poorly differentiated adenocarcinoma CLICK TO VIEW
LU5151 Lung Cancer NSCLC, ADC adenocarcinomamoderately differentiated pulmonary adenocarcinoma CLICK TO VIEW
LU5152 Lung Cancer NSCLC, ADC adenocarcinoma non-small cell carcinoma, spindle cell type CLICK TO VIEW
LU5153 Lung Cancer NSCLC, ADC adenocarcinomapoorly-differentiated adenocarcinoma CLICK TO VIEW
LU5155 Lung Cancer NSCLC, ADC adenocarcinomametastatic adenocarcinoma CLICK TO VIEW
LU5157 Lung Cancer NSCLC, ADC adenocarcinomanon-small cell lung carcinoma, favor adenocarcinoma CLICK TO VIEW
LU5159 Lung Cancer SCLC adenocarcinomaadenocarcinoma with focal squamous (less than 20%) differentiation as well as clear cell differentiation CLICK TO VIEW
LU5160 Lung Cancer NSCLC, ADC adenocarcinomasolid-predominant adenocarcinoma CLICK TO VIEW
LU5161 Lung Cancer NSCLC, SCC non-small cell lung cancer metastatic carcinoma with clear cell features CLICK TO VIEW
LU5162 Lung Cancer NSCLC, ADC non-small cell lung cancer metastatic poorly differentiated carcinoma CLICK TO VIEW
LU5165 Lung Cancer NSCLC, ADC adeno CLICK TO VIEW
LU5167 Lung Cancer SCLC broncogenic small cell lung cancer CLICK TO VIEW
LU5171 Lung Cancer SCLC small cell lung carcinoma small cell lung carcinoma CLICK TO VIEW
LU5172 Lung Cancer NSCLC (KRAS mut) non-small cell lung cancer. Pathol comment: tumor cells present in cell block c/w referring diagnosis. tumor cells present in cytospin prep. CLICK TO VIEW
LU5173 Lung Cancer SCLC Small Cell Lung Carcinoma. Pathol comment: The tissue contains 70% tumor c/w referring diagnosis. Tumor cells present in cytospin prep. CLICK TO VIEW
LU5174 Lung Cancer NSCLC non-small cell lung cancer. Pathol comment: c/w referring diagnosis. approximately 90% of the tissue involved by tumor in sections examined. tumor cells present in cytospin prep. CLICK TO VIEW
LU5175 Lung Cancer NSCLC NA CLICK TO VIEW
LU5176 Lung Cancer NSCLC, ADC (KRAS mut) non-small cell lung cancer adenocarcinoma. Pathol comment: uncertain tumor cells present in cell block. rare tumor cells present in cytospin prep. CLICK TO VIEW
LU5178 Lung Cancer SCLC small cell lung carcinomaoat cell carcinoma. Pathol comment: c/w referring diagnosis. malignant tumor cells present in cell block and cytospin prep. CLICK TO VIEW
LU5179 Lung Cancer SCLC small cell lung carcinomaanaplastic carcinoma, small cell type. Pathol comment: approximately 60% of the tissue involved by malignant tumor in sections examined. 60% necrosis. malignant tumor cells present in cytospin prep. CLICK TO VIEW
LU5180 Lung Cancer SCLC small cell lung carcinomametastatic small cell carcinoma of lung. Pathol comment: c/w diagnosis. approximately 90% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep. CLICK TO VIEW
LU5181 Lung Cancer NSCLC, SCC N/A CLICK TO VIEW
LU5183 Lung Cancer SCLC small cell lung carcinomametastatic small cell undifferentiated carcinoma. Pathol comment: c/w referring diagnosis. entire tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep. CLICK TO VIEW
LU5184 Lung Cancer SCLC small cell lung carcinoma. Pathol comment: c/w referring diagnosis. microscopic focus of malignant tumor present in sections examined. malignant tumor cells present in cytospin prep. CLICK TO VIEW
LU5185 Lung Cancer NSCLC, SCC non-small cell lung carcinoma squamous carcinoma. Pathol comment: approximately 30% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep. CLICK TO VIEW
LU5187 Lung Cancer NSCLC non-small cell lung cancer. Pathol comment: c/w referring diagnosis. malignant tumor cells present in cell block section and cytospin prep. CLICK TO VIEW
LU5188 Lung Cancer SCLC small cell lung carcinomaneuroendocrine carcinoma, pd. Pathol comment: c/w referring diagnosis. entire tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep. CLICK TO VIEW
LU5190 Lung Cancer NSCLC, SCC non-small cell lung cancer metastatic squamous cell carcinoma, pd. Pathol comment: c/w diagnosis. approximately 50% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep. CLICK TO VIEW
LU5191 Lung Cancer NSCLC (KRAS mut) non-small cell lung. Pathol comment: c/w referring diagnosis. entire tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep. CLICK TO VIEW
LU5192 Lung Cancer SCLC small cell lung carcinoma. Pathol comment: c/w diagnosis. approximately 60% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep. CLICK TO VIEW
LU5193 Lung Cancer NSCLC non-small cell lung cancer. Pathol comment: c/w referring diagnosis. malignant tumor cells present in cell block section and cytospin prep. CLICK TO VIEW
LU5194 Lung Cancer NSCLC non-small cell lung cancer. Pathol comment: c/w referring diagnosis. malignant tumor cells present in cell block section and cytospin prep. CLICK TO VIEW
LU5196 Lung Cancer SCLC small cell lung carcinoma metastatic small cell carcinoma. Pathol comment: c/w diagnosis. approximately 80% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep. CLICK TO VIEW
LU5197 Lung Cancer SCLC small cell lung carcinomasmall cell carcinoma. Pathol comment: c/w diagnosis. approximately 50% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep. CLICK TO VIEW
LU5199 Lung Cancer NSCLC (KRAS mut) non-small cell lung cancer. Pathol comment: c/w referring diagnosis. malignant tumor cells present in cell block and cytospin prep. CLICK TO VIEW
LU5200 Lung Cancer NSCLC (KRAS mut) non-small cell lung cancer. Pathol comment: c/w diagnosis. approximately 60% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep. CLICK TO VIEW
LU5202 Lung Cancer SCLC small cell lung carcinoma. Pathol comment: c/w diagnosis. approximately 50% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep. CLICK TO VIEW
LU5203 Lung Cancer SCLC, matched sites small cell lung carcino mametastatic pd carcinoma. Pathol comment: c/w diagnosis. approximately 70% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep. CLICK TO VIEW
LU5204 Lung Cancer NSCLC, ADC non-small cell lung cancer squamous cell lung carcinoma. Pathol comment: c/w referring diagnosis. rare malignant tumor cells present in cell block section. malignant tumor cells present in cytospin prep. CLICK TO VIEW
LU5206 Lung Cancer SCLC small cell lung carcinoma. Pathol comment: c/w diagnosis. approximately 40% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep. CLICK TO VIEW
LU5207 Lung Cancer SCLC small cell lung carcinoma. Pathol comment: c/w referring diagnosis. malignant tumor cells present in cell block and cytospin prep. CLICK TO VIEW
LU5208 Lung Cancer NSCLC (KRAS mut) (EGFR 2+) Non-Small Cell Lung Cancer. Pathol comment: c/w diagnosis. approximately 70% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep. CLICK TO VIEW
LU5209 Lung Cancer NSCLC non-small cell lung cancer. Pathol comment: c/w referring diagnosis. malignant tumor cells present in cell block and cytospin prep. CLICK TO VIEW
LU5210 Lung Cancer SCLC small cell lung carcinoma. Pathol comment: c/w diagnosis. approximately 90% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep. CLICK TO VIEW
LU5211 Lung Cancer NSCLC, ADC (EGFR hi) non-small cell lung cancer adenocarcinoma. Pathol comment: c/w diagnosis. approx. 10% of the tissue involved by malignant tumor in sections examined. 20% necrotic. malignant tumor cells in cytospin prep. CLICK TO VIEW
LU5212 Lung Cancer NSCLC non-small cell lung cancer. Pathol comment: c/w referring diagnosis. microscopic focus of malignant tumor present in sections examined. malignant tumor cells present in cytospin prep. CLICK TO VIEW
LU5213 Lung Cancer NSCLC (EGFR hi) non-small cell lung cancermetastatic adenocarcinoma. Pathol comment: c/w diagnosis. approximately 70% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep. CLICK TO VIEW
LU5215 Lung Cancer SCLC small cell lung carcinoma metastatic carcinoma. Pathol comment: c/w diagnosis. approximately 100% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep. CLICK TO VIEW
LU5216 Lung Cancer SCLC small cell lung carcinoma. Pathol comment: c/w diagnosis. approximately 70% of the tissue involved malignant tumor in sections examined. 20% necrotic. malignant cells present in cytospin prep. CLICK TO VIEW
LU5217 Lung Cancer SCLC small cell lung carcinomasmall cell carcinoma. Pathol comment: c/w diagnosis. approximately 35% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep. CLICK TO VIEW
LU5218 Lung Cancer SCLC small cell lung carcinoma. Pathol comment: c/w diagnosis. approximately 35% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep. CLICK TO VIEW
LU5220 Lung Cancer SCLC small cell lung carcinoma. Pathol comment: c/w diagnosis. approximately 80% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep. CLICK TO VIEW
LU5221 Lung Cancer NSCLC, ADC (EGFR hi) non-small cell lung cancer adenocarcinoma with clear cell change , pd. Pathol comment: c/w diagnosis. approximately 80% of the tissue involved malignant tumor in sections examined. 5% necrotic. malignant cells present in cytospin prep. CLICK TO VIEW
LU5223 Lung Cancer SCLC small cell lung carcinomametastatic carcinoma, ud. Pathol comment: c/w diagnosis. approximately 80% of the tissue involved malignant tumor in sections examined. 10% necrotic. malignant cells present in cytospin prep. CLICK TO VIEW
LU5228 Lung Cancer SCLC small cell lung carcinoma. Pathol comment: approximately 20% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep. CLICK TO VIEW
LU5229 Lung Cancer NSCLC non-small cell lung cancer. Pathol comment: c/w diagnosis. approximately 60% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep. CLICK TO VIEW
LU5230 Lung Cancer NSCLC non-small cell lung cancer. Pathol comment: c/w diagnosis. approximately 70% of the tissue involved malignant tumor in sections examined. focal tumor necrosis. malignant tumor cells present in cytospin prep. CLICK TO VIEW
LU5231 Lung Cancer SCLC non-small cell lung cancer non-small cell carcinoma w/ neuroendocrine features. Pathol comment: c/w diagnosis. approximately 40% of the tissue involved by malignant tumor in sections examined. 10% necrotic. small cell carcinoma present. malignant tumor cells present in cytospin prep. CLICK TO VIEW
LU5233 Lung Cancer SCLC small cell lung carcinoma. Pathol comment: c/w diagnosis. approximately 50% of the tissue involved by malignant tumor in sections examined. focal tumor necrosis. malignant tumor cells present in cytospin prep. CLICK TO VIEW
LU5234 Lung Cancer SCLC small cell lung carcinoma. Pathol comment: c/w diagnosis. approximately 95% of the tissue involved by malignant tumor in sections examined. focal tumor necrosis. malignant tumor cells present in cytospin prep. CLICK TO VIEW
LU5236 Lung Cancer SCLC small cell lung carcinoma. Pathol comment: c/w diagnosis. approximately 50% of the tissue involved by malignant tumor in sections examined. 10% necrosis. c/w small cell carcinoma. approximately 90% malignant tumor cells present in cytospin preparation. CLICK TO VIEW
LU5237 Lung Cancer NSCLC, ADC h/o non-small cell lung cancer metastatic adenocarcinoma, mpd. Pathol comment: c/w diagnosis. approximately 30% of the tissue involved by malignant tumor in sections examined. 20% necrosis. approximately 60% malignant tumor cells present in cytospin preparation. CLICK TO VIEW
LU5238 Lung Cancer SCLC small cell lung carcinoma small cell carcinoma. Pathol comment: c/w diagnosis. approximately 80% of the tissue involved by malignant tumor in sections examined. 10% necrosis. approximately 80% malignant tumor cells present in cytospin preparation. CLICK TO VIEW
LU5242 Lung Cancer SCLC small cell carcinoma. Pathol comment: c/w diagnosis. approximately 90% of the tissue involved by malignant tumor in sections examined. approximately 70% malignant tumor cells present in cytospin preparation. CLICK TO VIEW
LU5243 Lung Cancer SCLC small cell carcinomametastatic small cell carcinoma of the lung. Pathol comment: c/w diagnosis. approximately 70% of the tissue involved by malignant tumor in sections examined. focal tumor necrosis. approximately 80% malignant tumor cells present in cytospin preparation. CLICK TO VIEW
LU5245 Lung Cancer NSCLC non-small cell lung cancer. Pathol comment: malignant tumor cells present in cell block. consistent with non-small cell carcinoma. approximately 50% malignant tumor cells present in cytospin preparation. CLICK TO VIEW
LU5247 Lung Cancer NSCLC non-small cell lung cancer. Pathol comment: approximately 70% of the tissue involved by malignant tumor in sections examined. 5% necrosis. c/w non-small cell carcinoma. approximately 70% malignant tumor cells present in cytospin preparation. CLICK TO VIEW
LU5248 Lung Cancer SCLC small cell carcinomasmall cell neuroendocrine carcinoma. Pathol comment: c/w diagnosis. microscopic detached fragments of malignant cells present in tissue sections examined. approximately 90% malignant tumor cells present in cytospin preparation. CLICK TO VIEW
LU5249 Lung Cancer SCLC small cell carcinoma. Pathol comment: c/w diagnosis. approximately 70% of the tissue involved by malignant tumor in sections examined. 20% tumor necrosis. approximately 80% malignant tumor cells present in cytospin preparation. CLICK TO VIEW
LU5250 Lung Cancer SCLC Small cell carcinoma. Pathol comment: c/w diagnosis. approximately 20% of the tissue involved by malignant tumor in sections examined. 20% tumor necrosis. approximately 70% malignant tumor cells present in cytospin preparation. CLICK TO VIEW
LU5251 Lung Cancer NSCLC, SCC non-small cell lung cancersquamous cell carcinoma. Pathol comment: c/w diagnosis. approximately 70% of the tissue involved by malignant tumor in sections examined. 70% necrosis. approximately 30% malignant tumor cells present in cytospin preparation. CLICK TO VIEW
LU5252 Lung Cancer NSCLC, ADC (KRAS mut) non-small cell lung cancer adenocarcinoma. Pathol comment: c/w diagnosis. approximately 10% of the tissue involved by malignant tumor in sections examined. approximately 70% malignant tumor cells present in cytospin preparation. CLICK TO VIEW
LU5255 Lung Cancer SCLC small cell carcinomasmall cell neuroendocrine carcinoma. Pathol comment: c/w diagnosis. approximately 10% of the tissue involved by malignant tumor in sections examined. focal tumor necrosis. approximately 40% malignant tumor cells present in cytospin preparation. CLICK TO VIEW
LU5256 Lung Cancer SCLC small cell carcinoma metastatic small cell carcinoma. Pathol comment: c/w diagnosis. approximately 90% of the tissue involved by malignant tumor in sections examined. 1% necrosis. approximately 80% malignant tumor cells present in cytospin preparation. CLICK TO VIEW
LU5257 Lung Cancer SCLC small cell lung carcinoma small cell carcinoma, intermediate cell size. Pathol comment: c/w diagnosis. approximately 60% of the tissue involved by malignant tumor in sections examined. focal tumor necrosis. approximately 80% malignant tumor cells present in cytospin preparation. CLICK TO VIEW
LU5258 Lung Cancer SCLC small cell carcinoma small cell carcinoma. Pathol comment: c/w diagnosis. approximately 70% of the tissue involved by malignant tumor in sections examined. marked crush artifact. approximately 70% malignant tumor cells present in cytospin preparation. CLICK TO VIEW
LU5260 Lung Cancer NSCLC, ADC (KRAS mut) non-small cell lung carcinoma poorly differentiated adenocarcinoma CLICK TO VIEW
LU5261 Lung Cancer SCLC small cell carcinoma small cell carcinoma of lung CLICK TO VIEW
LU5262 Lung Cancer NSCLC non-small cell lung cancer poorly differentiated non-small cell carcinoma CLICK TO VIEW
LU5263 Lung Cancer SCLC small cell carcinoma small cell carcinoma CLICK TO VIEW
LU5264 Lung Cancer SCLC small cell carcinoma. CLICK TO VIEW
LU5265 Lung Cancer SCLC small cell lung carcinoma small cell carcinoma CLICK TO VIEW
LU5266 Lung Cancer SCLC small cell carcinoma metastatic small cell carcinoma compatible with previous lung primary CLICK TO VIEW
LU5268 Lung Cancer NSCLC, ADC (KRAS mut) lung carcinoma metastatic adenocarcinoma c/w primary lung CLICK TO VIEW
LU5269 Lung Cancer SCLC small cell carcinoma-- CLICK TO VIEW
LU5271 Lung Cancer SCLC small cell carcinoma-- CLICK TO VIEW
LU5349 Lung Cancer NSCLC Non-small cell lung carcinoma. Metastatic. Pathol comment: APPROXIMATELY 70% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. FOCAL TUMOR NECROSIS. C/W NON-SMALL CELL CARCINOMA. APPROXIMATELY 80% MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREPARATION. CLICK TO VIEW
LU5350 Lung Cancer NSCLC Non-small cell lung carcinoma. Pathol comment: APPROXIMATELY 70% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. FOCAL TUMOR NECROSIS. C/W NON-SMALL CELL CARCINOMA. APPROXIMATELY 80% MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREPARATION. CLICK TO VIEW
LU5351 Lung Cancer NSCLC metastatic carcinoma. Pathol comment: APPROXIMATELY 70% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. FOCAL TUMOR NECROSIS. C/W NON-SMALL CELL CARCINOMA. APPROXIMATELY 80% MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREPARATION. CLICK TO VIEW
LU5355 Lung Cancer NSCLC metastatic squamous cell carcinoma CLICK TO VIEW
LU5369 Lung Cancer NSCLC Non-Small Cell Lung Cancer. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
LU5371 Lung Cancer NSCLC Non-Small Cell Lung Cancer. Pathol comment: C/W REFERRING DIAGNOSIS. MICROSCOPIC FOCUS OF MALIGNANT TUMOR PRESENT IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
LU5377 Lung Cancer SCLC oat cell CLICK TO VIEW
LU5378 Lung Cancer SCLC Small Cell Lung Carcinoma. Pathol comment: C/W REFERRING DIAGNOSIS. APPROXIMATELY 70% OF THE TISSUE INVOLVED BY TUMOR IN SECTIONS EXAMINED. TUMOR CELLS PRESENT IN CYTOSPIN PREP CLICK TO VIEW
LU5381 Lung Cancer NSCLC Non-Small Cell Lung Cancer. Pathol comment: C/W REFERRING DIAGNOSIS. MALIGNANT TUMOR CELLS PRESENT IN CELL BLOCK SECTION AND CYTOSPIN PREP. CLICK TO VIEW
LU5386 Lung Cancer SCLC Small Cell Lung Carcinoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 80% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
LU5401 Lung Cancer NSCLC Non-Small Cell Lung Cancer. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 70% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. 30% NECROSIS. TUMOR CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
LU5406 Lung Cancer NSCLC Metastatic Brain Tumor. Pathol comment: APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
LU5407 Lung Cancer NSCLC Non-Small Cell Lung Cancer. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 80% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
LU5408 Lung Cancer NSCLC Non-Small Cell Lung Cancer. Pathol comment: C/W DIAGNOSIS. APPROX. 10% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. 80% NECROTIC. MALIGNANT TUMOR CELLS IN CYTOSPIN PREP. CLICK TO VIEW
LU5409 Lung Cancer NSCLC Non-Small Cell Lung Cancer. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 50% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
LU6266 Lung Cancer NSCLC N/A CLICK TO VIEW
LU6277 Lung Cancer NSCLC N/A CLICK TO VIEW
LU6307 Lung Cancer NSCLC, SCC squamous cell carcinoma CLICK TO VIEW
LU6402 Lung Cancer NSCLC, SCC Squamous cell Carcinoma - T2a N1 Mx R0 CLICK TO VIEW
LU6403 Lung Cancer NSCLC, SCC Non-Small Cell Lung Cancer, SCC CLICK TO VIEW
LU6404 Lung Cancer NSCLC, SCC Squamous cell carcinoma - pT3 pN1 pMx CLICK TO VIEW
LU6405 Lung Cancer NSCLC, ADS Adenosquamous carcinoma Grade 3 - pT2a, N1, Mx CLICK TO VIEW
LU6406 Lung Cancer NSCLC, SCC Poorly differentiated SCC pT1b Nx Mx, V0 CLICK TO VIEW
LU6407 Lung Cancer NSCLC, SCC SCC pT2a pN0 pMx complete resection CLICK TO VIEW
LU6408 Lung Cancer NSCLC, SCC SCC of the lung pT3 pN1 pM0, complete resection CLICK TO VIEW
LU6410 Lung Cancer NSCLC, ADS Moderately differentiated adenosquamous carcinoma with clear cell pattern - pT2a, pN0, pMX V0- complete resection CLICK TO VIEW
LU6411 Lung Cancer NSCLC, SCC Moderately differentiated SCC - pT2b, N1, pM0, V0 - complete resection CLICK TO VIEW
LU6412 Lung Cancer NSCLC, ADC Adenocarcinoma of the lung - pT3, pN0, pMX V0- complete resection CLICK TO VIEW
LU6414 Lung Cancer NSCLC, ADC Adenocarcinoma of the lung - pT2a, pN1, pMX V0- complete resection CLICK TO VIEW
LU6415 Lung Cancer LCNEC Large cell neuroendocrine T2a N0 Mx V0 CLICK TO VIEW
LU6416 Lung Cancer NSCLC, SCC 2 Primaries - larger tumour-SCC T2a, N1, M0, V0. Other tumour- large cell neuroendocrine carcinoma T3. CLICK TO VIEW
LU6418 Lung Cancer NSCLC N/A CLICK TO VIEW
LU6419 Lung Cancer NSCLC, SCC Squamous cell carcinoma. T2a, N0, M0, R0 CLICK TO VIEW
LU6420 Lung Cancer NSCLC, SCC Squamous Cell Carcinoma, T2b, N0, M0, R0 CLICK TO VIEW
LU6421 Lung Cancer LCNEC Large Cell Neuroendocrine Carcinoma. T1b, N0, MX, R0 CLICK TO VIEW
LU6422 Lung Cancer NSCLC, ADC Adenocarcinoma of the Lung. T2a, N0, M0, R0 CLICK TO VIEW
LU6423 Lung Cancer NSCLC, SCC Squamous Cell Carcinoma of the lung. T2a, N0, M0, R0 CLICK TO VIEW
LU6424 Lung Cancer NSCLC, ADC NSCLC, ADC CLICK TO VIEW
LU6425 Lung Cancer NSCLC, ADC Adenocarcinoma of the Lung. pT2b, N1, M0, R0. CLICK TO VIEW
LU6426 Lung Cancer NSCLC, SCC NSCLC, SCC CLICK TO VIEW
LU6427 Lung Cancer NSCLC, ADC Adenocarcinoma left lung. pT2a, N2, M0, R0 CLICK TO VIEW
LU6428 Lung Cancer NSCLC, SCC NSCLC, SCC CLICK TO VIEW
LU6429 Lung Cancer NSCLC, SCC Squamous cell carcinoma of the Lung. pT3, N0, M0, R0 CLICK TO VIEW
LU6431 Lung Cancer NSCLC, SCC Squamous cell carcinoma left lung pT3, pN2 pM0 complete resection - yes CLICK TO VIEW
LU6432 Lung Cancer NSCLC, SCC NSCLC, SCC CLICK TO VIEW
LU6433 Lung Cancer NSCLC, SCC NSCLC, SCC CLICK TO VIEW
LU6434 Lung Cancer NSCLC, SCC Squamous cell carcinoma of the lung with focal glandular differentiation pT3 N0 M0 V0 R0 CLICK TO VIEW
LU6436 Lung Cancer NSCLC, SCC NSCLC, Squamous Cell Carcinoma CLICK TO VIEW
LU6437 Lung Cancer NSCLC, SCC NSCLC, SCC CLICK TO VIEW
LU6438 Lung Cancer NEC Poorly differentiated malignant tumour T2a N0 M0 V0 R0. UPDATE- in view of the absence of an alternative primary site we regard this tumour as a poorly differentiated non-small cell carcinoma of the lung. CLICK TO VIEW
LU6439 Lung Cancer NSCLC, SCC NSCLC, SCC CLICK TO VIEW
LU6440 Lung Cancer NSCLC, SCC Poorly differentiated SCC. pT2a, pN0, pM0, V0, R0 CLICK TO VIEW
LU6442 Lung Cancer NSCLC, ADC NSCLC, ADC CLICK TO VIEW
LU6471 Lung Cancer NSCLC, SCC Moderately differentiated SCC - pT2b, N1, pM0, V0 - complete resection CLICK TO VIEW
LU6473 Lung Cancer LCNEC LCNEC CLICK TO VIEW
LU6477 Lung Cancer NSCLC, SCC NA CLICK TO VIEW
LU6479 Lung Cancer NSCLC, SCC N/A CLICK TO VIEW
LU6481 Lung Cancer NSCLC, SCC N/A CLICK TO VIEW
LU6483 Lung Cancer N/A N/A CLICK TO VIEW
LU6484 Lung Cancer NSCLC, SCC NSCLC, SCC CLICK TO VIEW
LU6800 Lung Cancer NSCLC NA for clinical diagnosis info. CLICK TO VIEW
LU6802 Lung Cancer NSCLC NA for clinical diagnosis info. CLICK TO VIEW
LU6901 Lung Cancer NSCLC, SCC Poorly differentiated squamous cell carcinoma CLICK TO VIEW
LU6903 Lung Cancer NSCLC NA for clinical diagnosis info. CLICK TO VIEW
LU6904 Lung Cancer ADC Lung: poorly differentiated adenocarcinoma CLICK TO VIEW
LU6905 Lung Cancer NSCLC NA for clinical diagnosis info. CLICK TO VIEW
LU6907 Lung Cancer NSCLC Lung, sarcoma CLICK TO VIEW
LU6908 Lung Cancer NSCLC Poorly differentiated squamous cell carcinoma CLICK TO VIEW
LU6910 Lung Cancer SCC Lung: poorly differentiated squamous cell carcinoma CLICK TO VIEW
LU6911 Lung Cancer NSCLC NA for clinical diagnosis info. CLICK TO VIEW
LU6912 Lung Cancer NSCLC, ADC Poorly differentiated adenocarcinoma CLICK TO VIEW
LU6913 Lung Cancer NSCLC, SCC Well differentiated squamous cell carcinoma CLICK TO VIEW
LU6914 Lung Cancer NA NA for clinical diagnosis info. CLICK TO VIEW
LU6917 Lung Cancer NSCLC, SCC Moderately differentiated squamous cell carcinoma CLICK TO VIEW
LU6918 Lung Cancer NSCLC, ADC Poorly differentiated adenocarcinoma CLICK TO VIEW
LU6919 Lung Cancer NSCLC, SCC Well differentiated squamous cell carcinoma CLICK TO VIEW
LU6920 Lung Cancer NA NA for clinical diagnosis info. CLICK TO VIEW
LU6921 Lung Cancer SCC Lung: poorly differentiated squamous cell carcinoma CLICK TO VIEW
LU6922 Lung Cancer NA NA for clinical diagnosis info. CLICK TO VIEW
LU6923 Lung Cancer NA NA for clinical diagnosis info. CLICK TO VIEW
LU9328 Lung Cancer NSCLC, ADC N/A CLICK TO VIEW
LU9333 Lung Cancer SCC NA CLICK TO VIEW
LU9334 Lung Cancer SCC NA CLICK TO VIEW
LU9335 Lung Cancer NSCLC N/A CLICK TO VIEW
LU9339 Lung Cancer NSCLC N/A CLICK TO VIEW
LU9342 Lung Cancer NSCLC N/A CLICK TO VIEW
LU9348 Lung Cancer NA NA CLICK TO VIEW
LU9349 Lung Cancer NA NA CLICK TO VIEW
LU9357 Lung Cancer SCC NA CLICK TO VIEW
LU9358 Lung Cancer NSCLC, SCC NA CLICK TO VIEW
LU9359 Lung Cancer NSCLC, ADC NA CLICK TO VIEW

Sorry, no posts matched your criteria.

Create Account to View All Model Data

Already Registered? Login